Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Land Use Development topic
No spam. Unsubscribe anytime.
Applicant wins board approval for one‑year extension of biopharmaceutical master plan
Summary
The Planning Board approved a one‑year extension for the master plan for the proposed biopharmaceutical facility (Rubius Therapeutics, ID 20009) after the applicant said prior approvals expire around Jan. 12, 2025; the motion passed with the board recording ayes (individual votes not listed in transcript).
Joe Casale, a registered professional engineer representing the project team, told the Planning Board the master‑plan approval for the proposed biopharmaceutical facility (identified in the record as Rubius Therapeutics, ID 20009) had been granted in December 2020 and that previously granted extensions will expire "on or about 01/12/2025." He asked the board "if you would give us 1 more year extension," saying the extra time would help the owner find tenants and clients and move the project through regulatory review.
A board member moved to approve the requested extension; another seconded. After a brief call for discussion, the board voted in favor and the chair declared "the ayes have it." The transcript does not list individual roll‑call votes or member names for that motion. No conditions or amendments to the extension were recorded in the transcript.
The applicant — represented at the hearing by Casale and Jason Tilley, vice president of acquisitions for Davis Companies LLC — framed the request as procedural: securing an additional year would preserve the team’s previously granted approvals while they seek tenants and finalize design and permitting tasks. Casale noted the team has received prior extensions but needs additional time to complete negotiations and predevelopment work.
The board did not request further technical reports or attach additional conditions on the extension during the public portion of the hearing. The decision was recorded as an affirmative vote; the transcript records the outcome but not individual vote names.
